Color is focused on testing for characterized genes (e.g. BRCA1, BRCA2, PTEN, etc.) which have an impact to an individuals risk of developing cancer. Environmental and other factors of course play a role, and most cancers are not caused by these genes. However, knowing that you are at high risk of developing cancer is something a patient can work on with their physician to develop a personalized screening and prevention plan. For example, national guidelines from NCCN suggest that women with a BRCA1 mutation get more frequent mammograms. See also cancer.gov risks for having a BRCA1 or BRCA2 mutation: https://www.cancer.gov/about-cancer/causes-prevention/geneti...
Color was developed working closely with some of the leading cancer researchers including Dr. Mary-Claire King, who is credited with discovering BCRA1, and Dr. Laura Esserman and Dr. Laura v'ant Veer at UCSF. Our team includes people with backgrounds in genetics, medicine, and clinical pathology as well as machine learning, big data, and systems engineering.
This unique combination of skills is really crucial to pushing this area forward. For example, the Komen Foundation (one of the world's biggest breast cancer foundation) held a conference I was part of the planning committee for at Rockefeller University last year on big data for breast cancer. http://ww5.komen.org/BD4BC.html
Marrying data science to medicine is a way to drive cancer research forward.
As an aside, one of Color's founders is a BRCA carriers whose mother had breast cancer twice, and whose grandmother died of the disease. So, it is a bit sad to me that the default assumption is we are "academic imperialists" versus people trying to do something good for the world.
Thanks for reading :)